sub:provenance {
beldoc: dce:description "Approximately 61,000 statements." ;
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title "BEL Framework Large Corpus Document" ;
pav:authoredBy sub:_6 ;
pav:version "1.4" .
sub:_5 prov:value "Conversely, because the TIF1? antisense-ribozymes had no effect on GAPDH mRNA levels (Fig. 1D, bottom panel), they appear to be specific for the TIF1? mRNAs. These data show that the TIF1? antisense-ribozymes specifically ablate expression of endogenous TIF1? mRNA. As seen in Figure 2B, CD11b, CD11c, and CD14 levels increased in response to PMA-treatment of U937 clones expressing the ?-gal antisense-ribozyme. However, expression did not increase in the TIF1? antisense-ribozyme stable U937 cell lines.." ;
prov:wasQuotedFrom pubmed:11711437 .
sub:_6 rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:11711437 ;
prov:wasDerivedFrom beldoc: ,
sub:_5 .
}